Institutional Ownership
Kaleido Biosciences Inc Com
CUSIP 483347100Common StockKLDOQ1 2026
13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
3
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
7 filings · latest May 10, 2022
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | May 10, 2022 | Fmr LLC | 13G/A | 0.2% | — | SEC |
| 2 | Feb 9, 2022 | Fmr LLC | 13G/A | 15.0% | — | SEC |
| 3 | Feb 16, 2021 | Harbourvest Partners L.P. | 13G | 5.1% | 1.83M | SEC |
| 4 | Feb 10, 2021 | Flagship Ventures Fund V, L.P. | 13D/A | 0.1% | 42.9K | SEC |
| 5 | Jan 11, 2021 | Fmr LLC | 13G/A | 10.3% | — | SEC |
| 6 | Jun 8, 2020 | Flagship Ventures Fund V, L.P. | 13D/A | 0.1% | 42.9K | SEC |
| 7 | Feb 7, 2020 | Fmr LLC | 13G | 6.9% | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Hantz Financial Services, Inc. | 350 | $0 |
| 2 | Bay Harbor Wealth Management, LLC | 2.3K | $0 |
| 3 | Rmg Wealth Management LLC | 70 | $0 |